OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)
Jürgen Eckes, Oliver Schmah, J. W. Siebers, et al.
BMC Cancer (2011) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Jürgen Eckes, Oliver Schmah, J. W. Siebers, et al.
BMC Cancer (2011) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
EPR: Evidence and fallacy
Joseph W. Nichols, You Han Bae
Journal of Controlled Release (2014) Vol. 190, pp. 451-464
Closed Access | Times Cited: 732
Joseph W. Nichols, You Han Bae
Journal of Controlled Release (2014) Vol. 190, pp. 451-464
Closed Access | Times Cited: 732
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
Roy van der Meel, Marcel H.A.M. Fens, Pieter Vader, et al.
Journal of Controlled Release (2014) Vol. 195, pp. 72-85
Closed Access | Times Cited: 427
Roy van der Meel, Marcel H.A.M. Fens, Pieter Vader, et al.
Journal of Controlled Release (2014) Vol. 195, pp. 72-85
Closed Access | Times Cited: 427
Odyssey of a cancer nanoparticle: From injection site to site of action
Joseph W. Nichols, You Han Bae
Nano Today (2012) Vol. 7, Iss. 6, pp. 606-618
Open Access | Times Cited: 346
Joseph W. Nichols, You Han Bae
Nano Today (2012) Vol. 7, Iss. 6, pp. 606-618
Open Access | Times Cited: 346
Accumulating nanoparticles by EPR: A route of no return
Romeo Ngoune, Annette Peters, Dominik von Elverfeldt, et al.
Journal of Controlled Release (2016) Vol. 238, pp. 58-70
Open Access | Times Cited: 196
Romeo Ngoune, Annette Peters, Dominik von Elverfeldt, et al.
Journal of Controlled Release (2016) Vol. 238, pp. 58-70
Open Access | Times Cited: 196
Cardiac spheroids as promising in vitro models to study the human heart microenvironment
Liudmila Polonchuk, Mamta Chabria, Laura Badi, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 191
Liudmila Polonchuk, Mamta Chabria, Laura Badi, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 191
Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
Oliver S. Thomas, Wilfried Weber
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 104
Oliver S. Thomas, Wilfried Weber
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 104
Fluorinated Organic Polymers for Cancer Drug Delivery
Jingrui Xin, Xue Lu, Ji-Min Cao, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 15
Jingrui Xin, Xue Lu, Ji-Min Cao, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 15
Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease
Antea Kršek, Lara Batičić
Future Pharmacology (2024) Vol. 4, Iss. 2, pp. 352-379
Open Access | Times Cited: 9
Antea Kršek, Lara Batičić
Future Pharmacology (2024) Vol. 4, Iss. 2, pp. 352-379
Open Access | Times Cited: 9
Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis
Gemma A. Figtree, Kristen J. Bubb, Owen Tang, et al.
Cells Tissues Organs (2017) Vol. 204, Iss. 3-4, pp. 191-198
Closed Access | Times Cited: 70
Gemma A. Figtree, Kristen J. Bubb, Owen Tang, et al.
Cells Tissues Organs (2017) Vol. 204, Iss. 3-4, pp. 191-198
Closed Access | Times Cited: 70
The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders
Ebenezeri Erasto Ngowi, Yizhen Wang, Lei Qian, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 48
Ebenezeri Erasto Ngowi, Yizhen Wang, Lei Qian, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 48
Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'
Naseem Akhtar, Riaz A. Khan
Progress in Lipid Research (2016) Vol. 64, pp. 192-230
Closed Access | Times Cited: 53
Naseem Akhtar, Riaz A. Khan
Progress in Lipid Research (2016) Vol. 64, pp. 192-230
Closed Access | Times Cited: 53
Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling
Joseph W. Nichols, Yu Sakurai, Hideyoshi Harashima, et al.
Journal of Controlled Release (2017) Vol. 267, pp. 31-46
Closed Access | Times Cited: 39
Joseph W. Nichols, Yu Sakurai, Hideyoshi Harashima, et al.
Journal of Controlled Release (2017) Vol. 267, pp. 31-46
Closed Access | Times Cited: 39
A Novel 3D Label-Free Monitoring System of hES-Derived Cardiomyocyte Clusters: A Step Forward to In Vitro Cardiotoxicity Testing
Heinz‐Georg Jahnke, Daniella Steel, Stephan Fleischer, et al.
PLoS ONE (2013) Vol. 8, Iss. 7, pp. e68971-e68971
Open Access | Times Cited: 33
Heinz‐Georg Jahnke, Daniella Steel, Stephan Fleischer, et al.
PLoS ONE (2013) Vol. 8, Iss. 7, pp. e68971-e68971
Open Access | Times Cited: 33
Breaking the Barrier of Cancer Through Liposome Loaded with Phytochemicals
Tapan Kumar Giri
Current Drug Delivery (2018) Vol. 16, Iss. 1, pp. 3-17
Closed Access | Times Cited: 30
Tapan Kumar Giri
Current Drug Delivery (2018) Vol. 16, Iss. 1, pp. 3-17
Closed Access | Times Cited: 30
pH Responsive Doxorubicin Delivery by Fluorous Polymers for Cancer Treatment
Jaqueline D. Wallat, Jada K. Harrison, Jonathan K. Pokorski
Molecular Pharmaceutics (2018) Vol. 15, Iss. 8, pp. 2954-2962
Closed Access | Times Cited: 27
Jaqueline D. Wallat, Jada K. Harrison, Jonathan K. Pokorski
Molecular Pharmaceutics (2018) Vol. 15, Iss. 8, pp. 2954-2962
Closed Access | Times Cited: 27
Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors
Darren L. Stirland, Yu Matsumoto, Kazuko Toh, et al.
Journal of Controlled Release (2016) Vol. 227, pp. 38-44
Open Access | Times Cited: 25
Darren L. Stirland, Yu Matsumoto, Kazuko Toh, et al.
Journal of Controlled Release (2016) Vol. 227, pp. 38-44
Open Access | Times Cited: 25
Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents
Andrew T. Lucas, Andrew J. Madden, William C. Zamboni
Expert Opinion on Drug Metabolism & Toxicology (2015) Vol. 11, Iss. 9, pp. 1419-1433
Closed Access | Times Cited: 17
Andrew T. Lucas, Andrew J. Madden, William C. Zamboni
Expert Opinion on Drug Metabolism & Toxicology (2015) Vol. 11, Iss. 9, pp. 1419-1433
Closed Access | Times Cited: 17
Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles
Hiroshi Nakata, Tatsuhiko Miyazaki, Tomoyuki Iwasaki, et al.
Oncology Reports (2015) Vol. 33, Iss. 4, pp. 1593-1598
Open Access | Times Cited: 14
Hiroshi Nakata, Tatsuhiko Miyazaki, Tomoyuki Iwasaki, et al.
Oncology Reports (2015) Vol. 33, Iss. 4, pp. 1593-1598
Open Access | Times Cited: 14
Comparison of the efficacy and safety of pegylated liposomal doxorubicin and epirubicin in neoadjuvant chemotherapy for HER2-negative breast cancer: a real-world case–control study
Lixian Yang, Shiyu Zhang, Lei Zheng, et al.
International Journal of Surgery Oncology (2024) Vol. 9, Iss. 1, pp. 10-14
Open Access | Times Cited: 1
Lixian Yang, Shiyu Zhang, Lei Zheng, et al.
International Journal of Surgery Oncology (2024) Vol. 9, Iss. 1, pp. 10-14
Open Access | Times Cited: 1
Nanotechnology for Cancer Treatment: Possibilities and Limitations
Joseph W. Nichols, You Han Bae
Springer eBooks (2013), pp. 37-56
Closed Access | Times Cited: 10
Joseph W. Nichols, You Han Bae
Springer eBooks (2013), pp. 37-56
Closed Access | Times Cited: 10
Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing
Romeo Ngoune, Christine Contini, Michael M. Hoffmann, et al.
Current Drug Delivery (2018) Vol. 15, Iss. 9, pp. 1261-1270
Open Access | Times Cited: 10
Romeo Ngoune, Christine Contini, Michael M. Hoffmann, et al.
Current Drug Delivery (2018) Vol. 15, Iss. 9, pp. 1261-1270
Open Access | Times Cited: 10
Targeted nanotherapy for kidney diseases: a comprehensive review
Gianmarco Sabiu, Vivek Kasinath, Sungwook Jung, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 6, pp. 1385-1396
Open Access | Times Cited: 6
Gianmarco Sabiu, Vivek Kasinath, Sungwook Jung, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 6, pp. 1385-1396
Open Access | Times Cited: 6
Plasmafiltration as a possible contributor to kinetic targeting of pegylated liposomal doxorubicin (PLD) in order to prevent organ toxicity and immunosuppression
Jiřina Martı́nková, M. Bláha, Ondřej Kubeček, et al.
Cancer Chemotherapy and Pharmacology (2015) Vol. 77, Iss. 2, pp. 429-437
Closed Access | Times Cited: 6
Jiřina Martı́nková, M. Bláha, Ondřej Kubeček, et al.
Cancer Chemotherapy and Pharmacology (2015) Vol. 77, Iss. 2, pp. 429-437
Closed Access | Times Cited: 6
Plasma filtration for the controlled removal of liposomal therapeutics – From the apheretic site of view
M. Bláha, Jiřina Martı́nková, M. Lánská, et al.
Atherosclerosis Supplements (2017) Vol. 30, pp. 286-293
Closed Access | Times Cited: 6
M. Bláha, Jiřina Martı́nková, M. Lánská, et al.
Atherosclerosis Supplements (2017) Vol. 30, pp. 286-293
Closed Access | Times Cited: 6
Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities
Anjan Motamarry, Amber Wolfe, Krishna Kumar Ramajayam, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1322-1322
Open Access | Times Cited: 4
Anjan Motamarry, Amber Wolfe, Krishna Kumar Ramajayam, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1322-1322
Open Access | Times Cited: 4
